Drug Distribution Flashcards
Bio availability
The amount of drug that reaches the reaches the circulation and is available for action
Drug distribution
The reversible transfer of a drug between blood and the extra vascular fluid and tissues of the body.
Factors that determine bio availability
- Formulation and mode of administration
- Ability of drug to pass physiological barriers
- GI effects
- First pass metabolism
Factors that determine drug distribution
- Plasma protein binding; only the unbound drug is biologically active.
- Tissue distribution
- Membrane characteristics
- Transport mechanisms
- Disease and other drugs
- Elimination
Tmax
Time to peak concentration
Cmax
The peak concentration
Vd
Apparent volume of distribution (L/Kg). The volume of plasma that would be necessary to account for the total amount of drug in a patients body, if that drug were present throughout the body at the same concentration as found in plasma. The greater the Vd the greater the ability of a drug to diffuse into/through membranes.
Cl
Clearance (ml/min); the theoretical volume from which a drug is completely removed over a period of time i.e. elimination. Dependant on concentration and urine flow rate for renal clearance. Dependant on metabolism and biliary excretion for hepatic clearance.
t1/2
half life; the time taken for the drug concentration in the blood to decline to half of the current volume.
t1/2 = 0.693Vd/Cl
Selective accumlation
Drugs will not always be uniformly distributed to and retained by body tissues. The concentrations of some drugs will be either considerably higher or lower in particular tissues that could be predicted on the basis of simple distribution assumptions.
Drug elimination
The removal of active drug and metabolites from the body. Determines length of action of drug.
Location of drug metabolism
Liver
Location of drug excretion
Usually kidney but also biliary system, gut and lung. `
Renal drug excretion
- Glomerular excretion/filtration
- Active tubular secretion
- Passive tubular re-absorption
Renal disease will slow excretion and therefore reduce Cl of a drug allowing toxic levels to build up.